Arab News, 15 December 2025: Saudi Food and Drug Authority (SFDA) has introduced a number of new digital health and safety systems.

The digital tools are being used to strengthen pharmacovigilance and oversight of cosmetic safety. The transformation began with the launch of the fully digital “Saudi Vigilance” platform, which has replaced paper-based adverse reaction reporting. Smart reporting forms and behavioural nudges have also improved data quality and completion rates, while centralised dashboards are providing real-time analysis of adverse events, enabling early detection of safety signals.

In addition, Robotic Process Automation (RPA) has been used to streamline medication safety processes by automating repetitive tasks such as report sorting and data checks, significantly improving efficiency. The SFDA has also integrated digital safety measures into hospital systems, delivering alerts and training materials directly to healthcare professionals. Finally, the Saudi Name Registration (SNR) platform is now improving drug name safety checks in both Arabic and English, reducing the risk of medication errors.

SFDA also plan to deploy artificial intelligence tools for cosmetic product safety, including automated ingredient checks and consumer feedback analysis.

For more news and content, try Lexis Middle East. Click on lexis.ae/demo to begin your free trial of Lexis® Middle East platform.

You can also explore the legal landscape by subscribing to our Weekly Newsletter.

Want to learn more about Lexis® Middle East? Visit https://www.lexis.ae/lexis-middle-east-law/.